Case 22

Case 22



HISTORY AND PHYSICAL EXAMINATION


A 60-year-old woman presented with a 5- to 10-year history of leg weakness and a sense of unsteadiness of insidious onset. Recently, she had become aware of mild impairment of sensation over the tips of the fingers and toes. She had mild low back pain with no radicular pain. For many years before this, she had aching discomfort in both feet, which worsened with activity and weight bearing.


Her medical history was benign, except for hypertension and chronic anxiety disorder. Her medications included alprazolam (Xanax®) and diltiazem (Cardizem®). Family history was relevant for a 30-year-old son with hammer toes, high-arched feet, and “thin legs” since childhood. She had a daughter and a maternal cousin with high-arched feet. Parents were deceased, with no definite history of neuromuscular disease.


The general examination was relevant for bilateral pes cavus deformities without hammer toes. There were no skin trophic changes. On neurologic examination, the fundi were normal without retinal pigmentary changes. Cranial nerves were normal. There was atrophy of all intrinsic muscles of both hands. Distal legs were thin with inverted-champagne bottle appearance. She could not wiggle her toes. Manual muscle examination revealed bilateral symmetrical weakness, worse distally. Toe flexors and extensors were 0/5 (Medical Research Council [MRC]), ankle dorsiflexors and plantar flexors were 4-/5, and hand intrinsics 4+/5. Deep tendon reflexes were +1 in the upper extremities but absent in the legs. Sensation revealed decreased position and vibration sense at the toes, and to a lesser extent at the ankles. Pin and touch sensation was relatively decreased in all four extremities, symmetrically worse distally with a stocking-and-glove distribution. Gait was steppage due to foot weakness. She could not walk on heels or toes. Romberg test was negative.


An electrodiagnostic (EDX) examination was performed.


Please now review the Nerve Conduction Studies and Needle EMG tables.




EDX FINDINGS AND INTERPRETATION OF DATA


Relevant EDX findings in this case include:




3. Marked slowing of motor distal latencies, conduction velocities, and F wave latencies in the upper extremities, along with moderate reduction of distal CMAP amplitudes (Figure C22-1). Distal latencies are 200 to 300% of the upper limit of normal values, conduction velocities are 45 to 50% of the lower limit of normal, and F wave latencies are 154 to 168% of the upper limit of normal values.




These findings are compatible with a chronic, demyelinating, sensorimotor peripheral polyneuropathy. Uniform and symmetrical slowing of motor conduction studies and the absence of conduction blocks are more consistent with an inherited, rather than an acquired, demyelinating polyneuropathy.


Based on the clinical manifestations, family history, and EDX findings, this case is consistent with an inherited demyelinating, sensorimotor peripheral polyneuropathy, as is seen with autosomal dominant hereditary motor sensory neuropathy (HMSN) type I (Charcot-Marie-Tooth disease type I).



DISCUSSION



Classification


Hereditary neuropathies are a heterogeneous group of peripheral nerve disorders (Figure C22-2). Some have a known metabolic basis and potential therapies (Table C22-1). The hereditary neuropathies that are not based on known specific metabolic defect are classified into three clinical groups: (1) hereditary motor and sensory neuropathies (HMSNs); (2) hereditary sensory and autonomic neuropathies (HSANs); and (3) hereditary motor neuropathies (HMNs).




The hereditary motor and sensory neuropathies (HMSNs) were classified by Dyck and Lambert into three predominant types (1) HMSN I, a demyelinating type; (2) HMSN II, a neuronal (axonal) type; and (3) HMSN III (Dejerine-Sottas disease), a severe demyelinating neuropathy of infancy and early childhood. HMSN I and II are characterized by skeletal deformities (pes cavus, hammer toes, scoliosis), insidious onset of distal lower more than upper extremities weakness, atrophy and sensory loss, and reduced or absent deep tendon reflexes. Based on clinical examination, these disorders are difficult to distinguish from each other because of similar phenotypes. With the recent influence of chromosomal linkage and gene identification, the term Charcot-Marie-Tooth disease (CMT) reemerged which created some confusion in the nomenclature and classifications of these disorders.


Charcot-Marie-Tooth disease (CMT) is subdivided into six major types with some but not perfect correlation to the HMSN classification (Table C22-2). CMT1 and CMT2 are interchangeable with HMSN I and HMSN II. The name Dejerine-Sottas syndrome (DSS, Dejerine-Sottas disease) is preserved and is the same condition as HMSN III. The term CMT3 is not commonly used since the genes involved with DSS are the same as CMT1. CMT4 is a new designation for a group of autosomal recessive CMT and should not be confused with HMSN IV which is Refsum disease. CMTX is an X-linked disorder and hereditary neuropathy with liability to pressure palsy (HNPP) is a distinct disorder characterized by recurrent mononeuropathies.


Table C22-2 Charcot-Marie-Tooth Disease (CMT, Hereditary Motor and Sensory Neuropathy, HMSN) Subtypes, Its Variants and Their Genetic Causes



















































































































Disorder Locus/Gene Protein
Charcot-Marie-Tooth Disease Type 1 (CMT1, HMSN I, Autosomal-Dominant, Demyelinating)
CMT1A 17p11.2-12/PMP22* Peripheral myelin protein 22
CMT1B 1q22-23/MPZ Myelin protein zero
CMT1C 16p13.1-12.3/LITAF SIMPLE
CMT1D 10q21.1-22.1/EGR2 Early growth response protein 2
Charcot-Marie-Tooth Disease Type 2 (CMT2, HMSN II, Autosomal-Dominant, Axonal)
CMT2A 1p35-36/KFI1B Kinesin-like protein Mitousin 2
CMT2B 3q13-22/RAB7 Ras-related protein
CMT2C 12q23-24/? ? (unknown)
CMT2D 7p15/GARS Glycy-tRNA synthetase
CMT2E 8P21/NEFL Neurofilament triplet L protein
CMT2F 7q11-21/HSP27 Small heat shock protein
CMT2 1q22/MPZ Myelin protein zero
Dejerine-Sottas Syndrome (DSS, HMSN III, CMT3, Autosomal-Dominant or Recessive, Demyelinating)
DSS A 17p/PMP22 Peripheral myelin protein 22
DSS B 1q/MPZ Myelin protein zero
DSS C 10q/EGR2 Early growth response protein 2
DSS D 8q23 Unknown
Charcot-Marie-Tooth Disease Type 4 (CMT4, Autosomal-Recessive, Axonal or Demyelinating)
CMT4A 8q13-21/GDAP1 Ganglioside-induced differentiation-associated protein-1
CMT4B1 11q22/MTMR2 Myotubularin-related protein-2
CMT4B2 11p15/MTMR13 Myotubularin-related protein-13
CMT4C 5q23-33/KIAA1985
CMT4D 8q24.3/NDRG1 N-myc downstream-regulated gene-1
CMT4E 10q21.1-22.1/EGR2 Early growth response protein 2
CMT4F 19q13.1-13.2/PRX Periaxin gene
X-linked Charcot-Marie-Tooth Disease (CMTX, Axonal or Demyelinating)
CMTX (X-linked) Xq13-q21/CX32(GJB1) Connexin 32 (gap junction protein-β-1)
Hereditary Neuropathy with Liability to Pressure Palsy (HNPP, Demyelinating)
HNPP (autosomal dominant) 17p11.22/PMP22 Peripheral myelin protein 22

* Duplication (98%) and point mutation (2%).


Deletion (80%) and point mutation (20%).


The hereditary sensory and autonomic neuropathies (HSANs) are very rare and familial neuropathies with selective involvement of the primary sensory, with or without the autonomic, fibers. They should be distinguished from inherited disorders that affect large primary afferent neurons (spinocerebellar degeneration). They are currently subdivided into five types, based on mode of inheritance, natural history, electrophysiologic characteristics and histopatologic findings (Table C22-3).


Table C22-3 Hereditary Sensory and Autonomic Neuropathy (HSAN)
























Disorder Locus/Gene Protein
HSAN I (hereditary sensory radicular neuropathy) 9q22.1-q22.3/SPTLC1 Serine-palitoyltransferase-1
HSAN II (congenital sensory neuropathy) 12p13-33
HSAN III (familial dysautonomia, Riley-Day syndrome) 9q31-33/IKBKAP Inhibitor of kappaB-kinase complex associated polypeptide
HSAN IV (congenital sensory neuropathy with anhidrosis) 1q21-22/TRKA
HSAN V 1q21-22/NTRK1

The hereditary motor neuropathies (HMNs) are loosely subdivided into proximal and distal (Table C22-4). The proximal HMNs are better known as spinal muscular atrophies (SMAs). These are among the most common autosomal recessive disorders in childhood affecting 1/10 000 live births with carrier frequency of 1/50. Spinal muscular atrophy is caused by a deficiency of the ubiquitous survival motor neuron (SMN) protein, which is encoded by the SMN genes, SMN1 and SMN2, on chromosome 5q. The distal HMNs are a genetically and clinically heterogeneous group of disorders that are also known as spinal CMT because of their overlap with CMT. They are characterized by distal weakness with or without foot deformities, but without sensory or autonomic involvement. Sensory nerve action potentials are normal while the motor NCSs reveal low-amplitude CMAPs with normal or borderline velocities, consistent with motor axonopathy. The inheritance of HMNs is either dominant or recessive. Only few have been mapped to a chromosome or have a defined gene mutation.


Table C22-4 Hereditary Motor Neuropathy (HMN)






























































Proximal HMN (Spinal Muscular Atrophy, SMA, Autosomal-Recessive, Mutations of the Survival Motor Neuron 1 (SMN 1) Gene on Chromosome 5q13)
SMA I Werdnig-Hoffmann disease. Onset before the age of 6 months, inability to sit or walk, and fatal before the age of 2 years
SMA II Intermediate, arrested Werdnig-Hoffmann disease. Onset between 6 and 18 months of age, able to sit but not walk and survive beyond the age of 4 years
SMA III Kugelberg-Welander disease
SMA IIIa Onset between the age of 2 to 3 years, survive into adulthood and able to walk independently usually until age 20–40 years
SMA IIIb Onset after the age of 3 years and able to walk independently till age 30–50 years
SMA IV Adult SMA. Variable age of onset, but rarely before the age of 20 years and usually after the age of 30 years
Bulbospinal (Kennedy Disease, X-Linked CAG Repeat Expansion of the Androgen Receptor Gene on Chromosome Xq13.1) Distal HMN (Spinal Form of Charcot-Marie-Tooth Disease)
HMN I Juvenile onset, autosomal dominant
HMN II Adult onset, autosomal dominant (12q24)
HMN III Mild juvenile, autosomal recessive (11q13)
HMN IV Severe juvenile, autosomal recessive
HMN V Upper limb predominance, autosomal dominant (7p)
HMN VI Severe infantile with respiratory distress, autosomal recessive
HMN VII Vocal cord paralysis, autosomal dominant (9p21.1-p12)
Scapuloperoneal
Type I Autosomal dominant
Type II Autosomal recessive
Bulbar
Type I Autosomal recessive (Vialetto-Van Laere syndrome)
Type II Autosomal recessive (Fazio-Londe disease)

Stay updated, free articles. Join our Telegram channel

Aug 12, 2016 | Posted by in CARDIOLOGY | Comments Off on Case 22

Full access? Get Clinical Tree

Get Clinical Tree app for offline access